Terug
Dagbereik
€ 163,77
€ 169,23
52-Weeksbereik
€ 134,65
€ 247,05
Volume
1.083.422
50D / 200D Gem.
€ 195,75
/
€ 195,50
Vorige Slotkoers
€ 166,96
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 20,7 | 0,3 |
| P/B | 4,3 | 2,9 |
| ROE % | 21,6 | 3,7 |
| Net Margin % | 8,3 | 3,8 |
| Rev Growth 5Y % | 4,1 | 10,0 |
| D/E | 2,5 | 0,2 |
Koersdoel Analisten
Hold
€ 233,80
+40.8%
Low: € 210,00
High: € 258,00
Forward K/W
13,2
Forward WPA
€ 12,70
WPA Groei (sch.)
+0,0%
Omzet Sch.
17 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 19,50
€ 19,25 – € 19,90
|
22 B | 6 |
| FY2029 |
€ 17,63
€ 17,39 – € 17,99
|
21 B | 6 |
| FY2028 |
€ 15,66
€ 13,24 – € 17,42
|
19 B | 8 |
Belangrijkste Punten
Revenue grew 4,13% annually over 5 years — modest growth
ROE of 21,64% indicates high profitability
Debt/Equity of 2,49 — high leverage
Generating 2,05B in free cash flow
Cash machine — converts 150,81% of earnings into free cash flow
Capital efficient — spends only 3,70% of revenue on capex
Groei
Revenue Growth (5Y)
4,13%
Revenue (1Y)5,87%
Earnings (1Y)-0,95%
FCF Growth (3Y)16,93%
Kwaliteit
Return on Equity
21,64%
ROIC7,56%
Net Margin8,34%
Op. Margin14,02%
Veiligheid
Debt / Equity
2,49
Current Ratio0,75
Interest Coverage3,14
Waardering
P/E Ratio
20,72
P/B Ratio4,33
EV/EBITDA18,53
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5,87% | Revenue Growth (3Y) | 4,33% |
| Earnings Growth (1Y) | -0,95% | Earnings Growth (3Y) | 0,07% |
| Revenue Growth (5Y) | 4,13% | Earnings Growth (5Y) | 8,93% |
| Profitability | |||
| Revenue (TTM) | 16,31B | Net Income (TTM) | 1,36B |
| ROE | 21,64% | ROA | 4,54% |
| Gross Margin | 26,28% | Operating Margin | 14,02% |
| Net Margin | 8,34% | Free Cash Flow (TTM) | 2,05B |
| ROIC | 7,56% | FCF Growth (3Y) | 16,93% |
| Safety | |||
| Debt / Equity | 2,49 | Current Ratio | 0,75 |
| Interest Coverage | 3,14 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 20,72 | P/B Ratio | 4,33 |
| P/S Ratio | 1,73 | PEG Ratio | 6,34 |
| EV/EBITDA | 18,53 | Dividend Yield | 0,00% |
| Market Cap | 28,19B | Enterprise Value | 42,38B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 16,31B | 15,41B | 14,98B | 14,41B | 13,87B |
| Net Income | 1,36B | 1,37B | 1,36B | 1,09B | 966,00M |
| EPS (Diluted) | 7,84 | 7,49 | 7,29 | 5,72 | 4,95 |
| Gross Profit | 4,29B | 5,38B | 5,24B | 5,03B | 4,64B |
| Operating Income | 2,29B | 2,20B | 1,98B | 1,80B | 1,39B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 29,94B | 26,90B | 26,68B | 25,34B | 24,69B |
| Total Liabilities | 23,31B | 20,83B | 20,57B | 19,57B | 18,65B |
| Shareholders' Equity | 6,50B | 6,07B | 6,11B | 5,77B | 6,04B |
| Total Debt | 16,17B | 14,16B | 13,90B | 13,01B | 12,44B |
| Cash & Equivalents | 1,98B | 1,70B | 1,38B | 1,22B | 1,37B |
| Current Assets | 6,25B | 5,83B | 5,60B | 4,98B | 4,76B |
| Current Liabilities | 8,34B | 6,96B | 6,49B | 5,58B | 5,24B |